Europe Embolotherapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Embolotherapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Embolotherapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Embolotherapy Market Regional Analysis

6.2 Europe Embolotherapy Market Revenue 2020-2028 (US$ Million)

6.3 Europe Embolotherapy Market Forecast Analysis

7. Europe Embolotherapy Market Analysis – by Product

7.1 Embolic Agent

7.1.1 Overview
7.1.2 Embolic Agent: Europe Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Support Device

7.2.1 Overview
7.2.2 Support Device: Europe Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Europe Embolotherapy Market Analysis – by Disease Indication

8.1 Cancer

8.1.1 Overview
8.1.2 Cancer: Europe Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Peripheral Vascular Disease

8.2.1 Overview
8.2.2 Peripheral Vascular Disease: Europe Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Neurological Disease

8.3.1 Overview
8.3.2 Neurological Disease: Europe Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Urological and Nephrological Disorder

8.4.1 Overview
8.4.2 Urological and Nephrological Disorder: Europe Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.5 Gastrointestinal Disorder

8.5.1 Overview
8.5.2 Gastrointestinal Disorder: Europe Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Europe Embolotherapy Market Analysis – by Procedure

9.1 Transcatheter Arterial Embolization

9.1.1 Overview
9.1.2 Transcatheter Arterial Embolization: Europe Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

9.2.1 Overview
9.2.2 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy: Europe Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Transarterial Chemoembolization

9.3.1 Overview
9.3.2 Transarterial Chemoembolization: Europe Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Europe Embolotherapy Market Analysis – by End User

10.1 Hospital & Clinic

10.1.1 Overview
10.1.2 Hospital & Clinic: Europe Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Ambulatory Surgery Center

10.2.1 Overview
10.2.2 Ambulatory Surgery Center : Europe Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. Europe Embolotherapy Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Embolotherapy Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 Europe Embolotherapy Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 UK: Europe Embolotherapy Market Breakdown, by Product
11.2.1.1.2 UK: Europe Embolotherapy Market Breakdown, by Disease Indication
11.2.1.1.3 UK: Europe Embolotherapy Market Breakdown, by Procedure
11.2.1.1.4 UK: Europe Embolotherapy Market Breakdown, by End User

11.2.1.2 Germany: Europe Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Germany: Europe Embolotherapy Market Breakdown, by Product
11.2.1.2.2 Germany: Europe Embolotherapy Market Breakdown, by Disease Indication
11.2.1.2.3 Germany: Europe Embolotherapy Market Breakdown, by Procedure
11.2.1.2.4 Germany: Europe Embolotherapy Market Breakdown, by End User

11.2.1.3 France: Europe Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 France: Europe Embolotherapy Market Breakdown, by Product
11.2.1.3.2 France: Europe Embolotherapy Market Breakdown, by Disease Indication
11.2.1.3.3 France: Europe Embolotherapy Market Breakdown, by Procedure
11.2.1.3.4 France: Europe Embolotherapy Market Breakdown, by End User

11.2.1.4 Russia: Europe Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Russia: Europe Embolotherapy Market Breakdown, by Product
11.2.1.4.2 Russia: Europe Embolotherapy Market Breakdown, by Disease Indication
11.2.1.4.3 Russia: Europe Embolotherapy Market Breakdown, by Procedure
11.2.1.4.4 Russia: Europe Embolotherapy Market Breakdown, by End User

11.2.1.5 Italy: Europe Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.5.1 Italy: Europe Embolotherapy Market Breakdown, by Product
11.2.1.5.2 Italy: Europe Embolotherapy Market Breakdown, by Disease Indication
11.2.1.5.3 Italy: Europe Embolotherapy Market Breakdown, by Procedure
11.2.1.5.4 Italy: Europe Embolotherapy Market Breakdown, by End User

11.2.1.6 Rest of Europe: Europe Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Embolotherapy Market Breakdown, by Product
11.2.1.6.2 Rest of Europe: Europe Embolotherapy Market Breakdown, by Disease Indication
11.2.1.6.3 Rest of Europe: Europe Embolotherapy Market Breakdown, by Procedure
11.2.1.6.4 Rest of Europe: Europe Embolotherapy Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Abbott Laboratories

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Boston Scientific Corporation

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Cook Medical LLC

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Johnson & Johnson

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Medtronic

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Acandis GmbH

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Balt USA LLC

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Stryker Corporation

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Guerbet LLC

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Terumo Corporation

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Embolotherapy Market